Skip to content
The Nexus
DossierENTITY

blood sugar targets

Coverage of blood sugar targets in the Nexus archive.

Earliest in view: Jun 5 · 15:13 UTCMost recent: Jun 5 · 15:13 UTC
Co-mentioned in this coverage
genetic variantstopic1GLP-1 drugstopic1Type 2 diabetestopic1GLP-1 resistancetopic1
Recent coverage
  • HEALTHJun 5 · 15:13 UTCSCIENCE DAILY
    Scientists discover why ozempic may not work for some people

    Scientists have identified genetic variants that may reduce the effectiveness of GLP-1 drugs for treating Type 2 diabetes in about 10% of the population. These variants appear to cause 'GLP-1 resistance,' making carriers less likely to achieve healthy blood sugar targets during clinical trials of these medications.